We are live on ! Find out more
TA

TRB Advisors Portfolio holdings

AUM $146M
1-Year Est. Return 3.71%
This Fund
S&P 500
This Quarter Est. Return
+15.67%
1 Year Est. Return
+3.71%
3 Year Est. Return
+42.28%
5 Year Est. Return
+63.5%
10 Year Est. Return
+539.21%
AUM
$214M
AUM Growth
+$113M
Cap. Flow
+$89.1M
Cap. Flow %
41.56%
Top 10 Hldgs %
100%
Holding
10
New
6
Increased
1
Reduced
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 52.28%
2 Financials 19.86%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$56.1M 26.15%
340,000
MSFT icon
2
Microsoft
MSFT
$2.84T
$49M 22.86%
170,000
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$40.9M 19.09%
+100,000
New +$39.9M
V icon
4
Visa
V
$677B
$25.9M 12.09%
115,000
+35,000
+44% +$7.79M
VOO icon
5
Vanguard S&P 500 ETF
VOO
$968B
$18.8M 8.77%
+50,000
New +$18.3M
FICO icon
6
Fair Isaac
FICO
$28.7B
$7.03M 3.28%
+10,000
New +$6.65M
SPGI icon
7
S&P Global
SPGI
$126B
$6.9M 3.22%
+20,000
New +$7.04M
MCO icon
8
Moody's
MCO
$81.7B
$6.12M 2.85%
+20,000
New +$6.04M
MA icon
9
Mastercard
MA
$477B
$3.63M 1.69%
+10,000
New +$3.63M
FNCH
10
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-19,000
Closed -$274K

Similar funds

TRB Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, TRB Advisors held 10 positions worth $214M, up 111% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRB Advisors deployed $89.1M of net new capital in Q1 2023, opening 6 new positions and adding to 1 existing holding. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 100,000 shares worth $40.9M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 83% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the most notable exit was Finch Therapeutics Group, Inc. Common Stock, an estimated $274K sold.

  • TRB Advisors's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 100,000 shares worth $40.9M.
  • TRB Advisors added most to Visa in Q1 2023, an estimated $7.79M increase.
  • TRB Advisors fully exited Finch Therapeutics Group, Inc. Common Stock in Q1 2023, selling an estimated $274K.
  • TRB Advisors's ten largest holdings make up 100% of its $214M portfolio in Q1 2023.
  • TRB Advisors opened 6 new positions and closed 1 in Q1 2023.
  • TRB Advisors's portfolio value rose 111% quarter-over-quarter to $214M.

Based on TRB Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.